Zosano Pharma Corp (ZSAN) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
ASSETS
Current assets:
Cash and cash equivalents	11.0	35.3	6.3	9.1	11.7	15.0	6.6	1.2
Accounts receivable	0.1
Prepaid expenses and other current assets	0.4	0.5	0.5	0.4	1.7	0.3	0.2	0.3
Total current assets	11.6	35.7	6.8	23.4	13.4	15.3	37.3	1.6
Property and equipment, net	32.6	30.9	24.6	11.9	4.2	5.5	7.7	9.7
Operating lease right-of-use assets	3.8	4.9	5.8
Total assets	48.4	72.0	37.7	35.8	18.0	20.9	45.3	13.3

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	2.1	1.9	4.4	4.5	1.5	1.4	1.2	1.4
Accrued compensation	1.8	2.3	2.0	2.1	1.6	1.4	1.3	1.7
Build-to-suit obligation, current portion, net of debt issuance costs and discount	3.8	4.8
Operating lease liabilities, current portion	1.6	1.4	1.1
Other accrued liabilities	1.8	3.4	4.2	2.4	0.7	1.0	1.0	1.0
Total current liabilities	11.1	14.5	16.2	11.3	10.5	9.8	6.9	13.4
Build-to-suit obligation, long-term portion, net of debt issuance costs and discount	1.0	4.4	6.1	4.5
Operating lease liabilities, long-term portion	3.1	4.7	5.9
Other long-term liabilities	0.2	0.1	0.0
Total liabilities	15.4	24.5	28.3	17.1	11.0	16.4	18.8	26.7

Commitments and contingencies (see note 11)
Stockholders’ equity:
Common stock	0.0	0.0	0.0	0.0			0.0	0.0
Additional paid-in capital	395.1	379.7	308.2	279.9	232.9	201.3	193.4	125.1
Accumulated deficit	-362.1	-332.2	-298.8	-261.2	-225.9	-196.8	-166.9	-138.5
Total stockholders’ equity	33.0	47.5	9.4	18.7	7.0	4.5	26.5	-13.4
Total liabilities and stockholders’ equity	48.4	72.0	37.7	35.8	18.0	20.9	45.3	13.3